Campuses: Home button

Florida Hospital

The skill to heal. The spirit to care.

Fundraising Priorities - Cardiovascular


The Trina Hidalgo Heart Care Center was founded by Florida Hospital to provide medical treatment to uninsured and economically disadvantaged heart care patients who do not have the financial means to manage their chronically debilitating disease. The clinic currently provides care for approximately 700 active heart failure and cardiology patients. The Heart Care Center has demonstrated an improvement in patient’s lives through the ongoing management of the uninsured patient’s care. While the national average hospital readmission rate remains at 23%, five years later, Florida Hospital’s rate has been maintained at 4% (down from 39% prior to the clinic opening). As of January 2013, additional philanthropic dollars are needed to continually sustain the program as funding is shared between Florida Hospital and dollars raised through the FH Cardiovascular Institute Foundation. Donors will contribute to the critical, often life saving care of hundreds of uninsured heart patients.


The number one cause of death in women over age 20 in the U.S. is cardiovascular disease. Florida Hospital desires to be a leader in the prevention, diagnosis and treatment of women with cardiovascular disease. The Cardiovascular Institute is conducting new research on a select group of premenopausal women at high risk for cardiovascular disease. The study will evaluate the impact Florida Hospital’s lifestyle management program called CHIP (Coronary Heart Improvement Program) has on modifying the risk factors for these young women. The goal is to advance the diagnosis and clinical treatment of cardiovascular disease in women. Donors will have the opportunity to contribute to this ground breaking study by providing the necessary screening tests at no cost for the study patients. As a result of this funded study, women in the community will have access to leading edge technology that aids in the diagnosis of cardiovascular disease in women. This technology is currently unavailable in central Florida Hospital.


There are many high-risk patients with structural heart disease like aortic stenosis for whom traditional cardiac surgery is not an option. Recently, the FDA approved a new technology called TAVR (Transcatheter Aortic Valve Replacement) that has the potential to add quality years to the lives of the elderly. It also can help those who suffer from calcified heart valves and are too ill to undergo traditional open-heart surgery. TAVR is an artificial collapsible valve that is inserted into the heart through a minimally invasive procedure conducted by a multi-disciplinary cardiac team. Donors will contribute to the initial launch of this program and, in so doing, further the technological advancement of heart valve replacement.